Urovant Sciences Ltd.·4

Jun 3, 6:50 PM ET

Johnston Walt 4

4 · Urovant Sciences Ltd. · Filed Jun 3, 2020

Insider Transaction Report

Form 4
Period: 2020-06-02
Johnston Walt
SVP, Commercial, USI
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-06-02+69,19769,197 total
    Exercise: $10.64Exp: 2030-06-02Common Shares (69,197 underlying)
  • Award

    Common Shares

    2020-06-02+108,647108,647 total
Footnotes (2)
  • [F1]25% of the Restricted Stock Units shall vest on June 1, 2021; the remaining Restricted Stock Units vest in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer through each such vesting date.
  • [F2]25% of the total shares underlying the option shall vest and become exercisable on June 1, 2021; the remaining shares vest in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer through each such vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION